Practice Test Geeks(ADM) Board Certified Addiction Medicine Specialist Practice Test
← All ADM Flashcard Decks

Treatment Protocols & Procedures Flashcards

7 cards from real ADM practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 7 Treatment Protocols & Procedures flashcards as text

  1. A patient with alcohol use disorder has failed naltrexone and acamprosate. Which third-line pharmacotherapy has off-label evidence for reducing heavy drinking days?

    Answer: Topiramate or gabapentin

    Topiramate and gabapentin have off-label evidence for reducing heavy drinking and are recommended as third-line options after FDA-approved medications.

  2. Which statement about disulfiram (Antabuse) for alcohol use disorder is accurate?

    Answer: It is most effective when supervised administration (e.g., by a family member or clinic) is ensured

    Disulfiram's effectiveness is highly dependent on adherence; supervised administration dramatically improves outcomes compared to unsupervised use.

  3. Which approach is recommended for managing opioid withdrawal symptoms (not dependence treatment) using the COWS scoring system?

    Answer: Clonidine for autonomic symptoms, NSAIDs for pain, antiemetics for nausea, and antidiarrheals for GI symptoms

    Non-opioid comfort medications targeting specific withdrawal symptoms (clonidine, NSAIDs, loperamide, antiemetics) manage opioid withdrawal without full MOUD.

  4. A 16-year-old with severe opioid use disorder presents for treatment. Which MOUD approach is consistent with current ASAM and AAP recommendations for adolescents?

    Answer: Buprenorphine is recommended and FDA-approved for adolescents 16 and older with OUD

    Buprenorphine is FDA-approved for OUD in patients 16 and older, and ASAM/AAP recommend offering MOUD to adolescents with OUD.

  5. In the MATRIX model for stimulant use disorder, which components are included?

    Answer: Individual counseling, group therapy, family education, 12-step facilitation, and urine drug testing

    The Matrix Model is a structured 16-week outpatient program combining individual/group therapy, family involvement, 12-step support, and drug testing for stimulant use disorders.

  6. A patient with OUD on buprenorphine/naloxone reports persistent cravings at their current dose of 16 mg/day. What is the most appropriate next step?

    Answer: Increase the buprenorphine/naloxone dose up to 24–32 mg/day if clinically indicated

    Buprenorphine can be dosed up to 24–32 mg/day; dose optimization should be attempted before switching to an alternative MOUD.

  7. Which of the following correctly describes the role of Screening, Brief Intervention, and Referral to Treatment (SBIRT) in addiction medicine?

    Answer: SBIRT is a universal screening approach used in primary care settings to identify risky substance use and intervene before disorders develop

    SBIRT is a public health framework deployed in primary care and other settings to screen all patients, intervene early for risky use, and connect those with disorders to treatment.